Comparison of laparoendoscopic single-site (LESS) and multiport laparoscopic radical nephrectomy for clinical T1b and T2a renal masses
| Autor: | Reza Mehrazin, Marc Holden, Zachary Hamilton, Hak J. Lee, Ithaar Derweesh, Abd-El R Hassan, Charles Field, Aaron Bloch, Sean Berquist, Michelle L. McDonald, Omer A. Raheem, Alp Tuna Beksac, Michael A. Liss |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Adult
Male medicine.medical_specialty Narcotic Urology medicine.medical_treatment Analgesic Operative Time Nephrectomy 03 medical and health sciences 0302 clinical medicine Postoperative Complications Carcinoma medicine Humans Carcinoma Renal Cell Aged Retrospective Studies business.industry Retrospective cohort study Endoscopy Perioperative Length of Stay Middle Aged medicine.disease Kidney Neoplasms Nephrology 030220 oncology & carcinogenesis Operative time 030211 gastroenterology & hepatology Laparoscopic radical nephrectomy Female Laparoscopy business |
| Zdroj: | Minerva urologica e nefrologica = The Italian journal of urology and nephrology. 69(6) |
| ISSN: | 1827-1758 |
| Popis: | BACKGROUND The aim of this study was to compare outcomes of laparoendoscopic single-site surgery (LESS) and multiport laparoscopic (MPL) radical nephrectomy (RN) for clinical T1b/T2a renal masses, as concerns continue regarding suitability and benefit of LESS for larger renal masses. METHODS Retrospective single-surgeon comparison of LESS- and MPL-RN between 7/2005 and 11/2014. Sixty-three patients underwent LESS-RN (44 cT1b/19 cT2a); 133 underwent MPL (83 cT1b/50 cT2a). All patients were managed with a standardized care pathway. Primary outcome was length of hospital stay (LOS). Secondary outcomes included operative time, estimated blood loss (EBL), complications, discharge pain score (visual analog pain, VAP), narcotic requirement (morphine equivalents, MSO4eq). RESULTS 130/133 MPL and 62/63 LESS were successfully performed. For MPL and LESS groups: mean tumor diameter (cm) for cT1b was 5.3 vs. 5.4 (P=0.689); and for cT2a was 8.2 vs. 8.3 (P=0.728); mean OR time (min) was 126.3 vs. 132.7 (P=0.314); mean EBL (mL) was 139.5 vs.127.8 (P=0.49). No significant differences in complications were noted (P=0.781). LESS was associated with significant reductions in LOS (2.14 vs. 2.45 days, P=0.043), discharge VAP (1.3 vs. 2.2, P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|